In normal stem cells, CD133 is mainly associated with cell proliferation [73], while in CSCs, it is involved in cancer cell proliferation, carcinogenesis, metastasis, recurrence, and chemoresistance [74, 75]. The gene discussed is PROM1; the disease is cancer.